NLRP12 and gastric cancer: To determine HK2 transcription and protein stability, gastric cancer cells were treated with CHX or ActD to block protein or mRNA synthesis, and HK2 degradation was evaluated over time (0, 3, 6 and 12 h) in NLRP12-deficient or NLRP12-overexpressing cells.